Waterloo researchers developing new glucose monitoring patch diabetes patients can attach themselvesThe tiny patch features an electro-chemical sensor and uses hundreds of microneedles to monitor glucose levels. Why does the Alzheimer’s brain become insulin-resistant?We still don’t know what cell types and mechanisms are involved in the action—and loss of action—of insulin in the brain. Prescriptions plummeted during the pandemic: study Manitoba study shows sudden drop in all drug classes. Undiagnosed diabetes may be common in hospitalized COVID-19 patients Study suggests measuring HbA1c in COVID-19 patients. U.S. FDA approves first drug that can help prevent type 1 diabetes The biologic drug, monoclonal antibody teplizumab, is approved for people eight years old and older who are in stage 2 of type 1 diabetes. Why South Asians are at increased risk for diabetes: A complex interplay of genetics, diet and history In Canada, 14.4% of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. A simple approach to improving gestational diabetes management Study shows patients on simple insulin regimen experienced improvements in all primary measures. Could recent advances present a genuine 'cure' for type 1 diabetes? Highlights from the European Association for the Study of Diabetes congress in Stockholm. Two new biosimilar insulins now available in Canada Viatris is introducing Kirsty (insulin aspart) and Semglee (insulin glargine). New treatment approved for CKD associated with type 2 diabetes Health Canada approves adjunct treatment for chronic kidney disease based on two trial results. First Previous 9 10 11 12 13 Next Last